Skip to Content

9 3 5213 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg)

Pill with imprint 9 3 5213 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 9 3 5213

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint
9 3 5213
Strength
12.5 mg / 7.5 mg
Color
Yellow
Size
10.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
ACE inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
lactose monohydrate, magnesium stearate, povidone k30, sodium bicarbonate, polyethylene glycol 3350, magnesium silicate, titanium dioxide, FD&C Yellow No. 5, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-5213 Teva Pharmaceuticals USA, Inc.
42291-0576 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.